SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-001483
Filing Date
2024-02-13
Accepted
2024-02-13 16:34:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 LYRA THERAPEUTICS, INC. p24-0812sc13g.htm SC 13G 58474
2 JOINT ACQUISITION STATEMENT exhibit99.htm EX-99.1 3962
  Complete submission text file 0000902664-24-001483.txt   64295
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Subject) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91508 | Film No.: 24626668
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 632 BROADWAY SUITE 602 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 602 NEW YORK NY 10012 6469894000
Vestal Point Capital, LP (Filed by) CIK: 0001974915 (see all company filings)

IRS No.: 922296021 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G